/
SELECTION OF AN ADJUVANT TO RAISE POLYCLONAL ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS SELECTION OF AN ADJUVANT TO RAISE POLYCLONAL ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS

SELECTION OF AN ADJUVANT TO RAISE POLYCLONAL ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS - PowerPoint Presentation

garcia
garcia . @garcia
Follow
1 views
Uploaded On 2024-03-13

SELECTION OF AN ADJUVANT TO RAISE POLYCLONAL ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS - PPT Presentation

Alison Morris Beatriz SanzBernardo Alison Burman Anna Ludi The Pirbright Institute Ash Road Pirbright Woking GU24 0NF UK Tel 44 01483 234455 Email beatrizsanzbernardopirbrightacuk ID: 1047006

injection adjuvant titremax inflammation adjuvant injection inflammation titremax pirbright site gold lesions day boost montanide prime pain adverse necropsy

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "SELECTION OF AN ADJUVANT TO RAISE POLYCL..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. SELECTION OF AN ADJUVANT TO RAISE POLYCLONAL ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS IN RABBITS AND GUINEA-PIGSAlison Morris | Beatriz Sanz-Bernardo | Alison Burman | Anna LudiThe Pirbright Institute, Ash Road, Pirbright, Woking, GU24 0NF UK. Tel: +44 (0)1483 234455. Email: beatriz.sanz-bernardo@pirbright.ac.uk www.pirbright.ac.uk

2. Aims and Experimental DesignAlternative to Freund’s adjuvant for the production of polyclonal antibodies.Good antibody titers but painful adverse effects.3 adjuvant candidates (water-in-oil-emulsions):Adjuvant 1 (TitreMax-Gold).Adjuvant 2 (Montanide ISA50_V2).Adjuvant 3 (Stimune).Immunization protocol:Prime inoculation followed by a boost on day 28.Serum: day 0, day 22 and day 42 (end of experiment)  indirect ELISA.

3. Testing antisera to the homologous antigenSuccessful antibody production in all adjuvants. Montanide > Stimune > TitreMax-Gold.TitreMax-Gold (boost of soluble antigen without adjuvant).Further work to be done:Specificity ELISA.

4. To the prime injection:Significant skin inflammation in GP with TitreMax-Gold.To the boost:No reactions were observed in Group 1 – GP and rabbits - (boosted with antigen in PBS).An increase inflammation during the boost (compared to prime injection) in rabbits of Groups 2 and 3.In GP the adverse effects were better characterized by the pain response, which was greater in Groups 2 and 3.AdjuvantSpeciesNumber of animalsReason for EuthanasiaTitreMax-GoldGP2Severe inflammation and pain of the injection site. Severe lesions upon necropsy.Rabbit2Severe inflammation of the injection site. Severe lesions upon necropsy.Montanide ISA50GP3Moderate inflammation and pain on the injection site. Moderete lesions upon necropsy.StimuneGP1Pain on the injection site no associated with lesions produced by the inoculum.Adverse reactionsWork in progress to refine the immunization protocol